SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as it approaches all-time highs, fueled by optimism around its robotaxi strategy and recent reports of battery expansion plans. Community members are actively discussing the potential for the stock to reach $500 soon, while some debate its valuation and compare it to competitors like Waymo. Bullish sentiment is high, with many anticipating further gains despite concerns about sales and profitability.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining attention as community members tout its potential within the cannabis culture and its similarities to Bitcoin. The coin, built on the Solana network, is promoted as a culture coin and a means to support the cannabis industry. Community members are actively sharing the contract address and promoting the project's vision for a 'greener future'.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as silver prices surge, prompting community discussion about potential gains and the stock's undervaluation relative to the metal's price. Traders are closely monitoring technical indicators and anticipating a breakout, with some highlighting the potential for significant returns as silver gains momentum. Speculation around market manipulation and the impact of broader economic factors are also driving conversations around AG.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices reach new highs, fueled by discussions around potential supply squeezes and increased industrial demand. Community members are debating the sustainability of the rally, citing factors like COMEX margin hikes and China's export policies, while others highlight silver's role in emerging technologies. The conversation also includes comparisons to gold and historical price movements, with some anticipating further gains.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as speculation mounts around potential cannabis rescheduling, possibly driven by an upcoming address from President Trump. The community is buzzing with anticipation, with some envisioning a significant price surge, reminiscent of past rallies, while others remain cautious about potential volatility and market manipulation in the sector. Many are pointing to credible news outlets reporting on the possibility of an executive order regarding reclassification.

The Children's Place, Inc. engages in the provision of apparel, footwear, accessories, and other items for children. The firm also designs contracts to manufacture and sell fashionable and value-priced merchandise under the brand names of The Children’s Place, Baby Place, and Gymboree. It operates through The Children’s Place U.S. and The Children’s Place International segments. The Children’s Place U.S. segment refers to the company’s U.S. and Puerto Rico-based stores and revenue from its U.S. based wholesale business. The Children’s Place International segment is involved in the Canadian-based stores, revenue from the company’s Canadian-based wholesale business, as well as revenue from international franchisees. The company was founded by David Pulver and Clinton A. Clark in 1969 and is headquartered in Secaucus, NJ.

Childrens Place Inc

Childrens Place ($PLCE) is trending due to its recent Q3 earnings report, which revealed a significant after-hours drop, with community members actively discussing the disappointing results. Despite some positive developments like refinancing and increased transformation savings, concerns linger around decreased net sales and tariffs. Community members are also discussing possible future outcomes for the stock, ranging from a dead cat bounce to bankruptcy.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

HYMC is trending as investors discuss Eric Sprott's continued accumulation of shares, fueling speculation about a potential move towards a 49% ownership stake and the company's upcoming catalysts. Community members are also highlighting the potential restart of heap leach operations in 2026 and the rising price of silver as factors that could drive future growth for the mining company. Some investors suggest Hycroft could benefit from AMC's reduced stake.

Global X Funds - Global X Silver Miners ETF

Global X Silver Miners ETF ($SIL) is trending as silver prices surge, driven by a mix of industrial demand and safe-haven interest, leading to community excitement about potential gains.  Many community members anticipate further upside for silver, with some calling for a catch-up rally in silver miners and leveraged plays, particularly if spot prices continue to climb, while other investors discuss allocation and debate between physical silver and ETFs. The ETF's movements are being closely watched within the context of broader discussions around inflation, market volatility, and the gold-to-silver ratio.

Amplify ETF Trust - Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF

SILJ is trending as silver continues its rally, reaching levels not seen in over a decade, with some community members anticipating a potential breakout. Community members are actively discussing the disconnect between silver's spot price and the performance of junior silver miners, speculating on a possible catch-up. Some analysts point to silver's undervalued status compared to gold, anticipating significant upside potential amid increasing industrial demand and a weaker dollar.

BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.

BGM Group Ltd. - Ordinary Shares - Class A

BGM Group Ltd

BGM is trending as community members actively discuss its AI-driven potential and recent chart activity, including a significant breakout. Community interest appears to be driven by the company's shift towards AI and robotics, as well as its potential for growth within the Chinese market. Some traders are noting technical indicators that may point to continued upward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Shkreli had earlier announced an investment in the company and expressed his desire to become the CEO.</li><li>Trading was twice halted within the first 15 minutes of the market opening.</li><li>QCLS said Martin Shkreli will add industry connections, early-stage growth expertise, and financial innovation insight as it scales its next-gen computing platform.</li></ul>Shares of Q/C Technologies, Inc. (QCLS) crashed over 13% in volatile trading on Tuesday, after the company appointed Martin Shkreli as a strategic advisor.Earlier in the session, <a href="https://stocktwits.com/symbol/QCLS">QCLS</a> had climbed more than 11%. However, trading was twice halted within the first 15 minutes of the market opening.<h2 class="st-heading-2">Shkreli Appointed Advisor</h2>The company said former hedge fund manager and pharmaceutical executive Martin Shkreli will bring industry connections, early-stage growth experience, and insights into financial innovation as it scales its next-generation computing platform.Shkreli joins an advisory roster that already includes noted technologist James Altucher, strengthening Q/C's expertise across computing, AI, and blockchain.“I'm convinced that the next leap in frontier computing is optical, not purely quantum. Q/C’s ‘quantum class’ technology approach bridges frameworks, offering the potential for extraordinary performance and efficiency gains,” Shkreli said.Q/C’s flagship QC-LPU100 laser processing units use light rather than electrical signals to deliver efficient, high-performance computing. In partnership with Lightsolver, the company is adapting its technology for real-world blockchain applications.In a post on X last week, Shkreli announced an investment in the company and expressed his desire to become the CEO. Shkreli also added that the near-term target for the stock was $100.<stembedurl>https://x.com/MartinShkreli/status/1996225504416792760</stembedurl>The stock surged 38% that day, followed by a 48% jump in the following session.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the intraday decline, retail sentiment on Stocktwits remained in the ‘extremely bullish’ territory, accompanied by ‘extremely high’ message volumes. QCLS was among the top trending tickers on Stocktwits.One user on the platform expects the stock to climb to $11. It is currently trading at $7.7.<stembedurl>https://stocktwits.com/PoplarAve/message/638553929</stembedurl>&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/what-is-purchasing-manager-s-index/cLIrUN7REZr">What Is Purchasing Manager’s Index?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Artistic representation of a trending chart.

‘Pharma Bro’ Martin Shkreli Becomes Strategic Advisor To This Company – Stock Slumps 13% In Volatile Session

QCLS stock had surged 11% before declining 13% in the first half hour of trade on Wednesday.

Equity

<ul class="summary-bullets"><li>Shkreli said that he would join the company as CEO if President Trump allowed it.</li><li>QCLS was formerly known as TNF Pharmaceuticals and announced a name change in September 2025 as it pivoted to become a quantum-class computing company.</li></ul>Q/C Technologies Inc. (QCLS) shares soared over 60% on Thursday, extending Wednesday’s gains as American pharma investor Martin Shkreli announced that he had purchased the company’s shares.“We bought a photonic/optical computing stock: $QCLS. I'm convinced that the answer to frontier computing is optical, not quantum. we're calling it "quantum class" so investors understand it,” Shkreli said in a post on X. He also added that he would join the company as CEO if President Trump allowed it.Shkreli also noted that his near-term target on the stock is $100. Currently, QCLS shares are trading around $7.<figure class="image"><a class="st-link-external" href="https://x.com/MartinShkreli/status/1996225504416792760" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1171/488;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_9_37_05_PM_png_4d4226b6e5.webp" alt="Shkreli said on X that he bought QCLS." width="1171" height="488"></a></figure><h2 class="st-heading-2"> Quantum Leaps</h2>Shkreli said that photonic technology delivers on the promise of quantum computing with realistic capabilities, while matrix multiplication could be far faster than GPUs.QCLS was formerly known as TNF Pharmaceuticals, Inc. (TNFA). The company announced a name change in September to represent its strategic pivot from pharmaceuticals to quantum-class computing.In October, the company obtained exclusive global digital rights to LightSolver’s laser processing unit (LPU) that can be used in the cryptocurrency verticals.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for the stock was ‘extremely bullish’ while message volume jumped to ‘extremely high’ at the time of writing. The stock was also the second-most-trending ticker on the platform.<figure class="image"><img style="aspect-ratio:1281/156;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_10_04_48_PM_png_ecefdba5d2.webp" alt="On Stocktwits, retail sentiment was ‘extremely bullish’ while message volume jumped to ‘extremely high’." width="1281" height="156"></figure>One user highlighted their positive take on the stock.<stembedurl>https://stocktwits.com/BullishBee/message/638169244</stembedurl>Another user noted that the stock was ready for another rally.<stembedurl>https://stocktwits.com/RM7391/message/638168492</stembedurl>Shares of QCLS are down over 98% year-to-date.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/brr-stock-jumps-after-ceo-pompiliano-accepts-1-salary-with-stock-incentives/cLIiP4NREjB">BRR Stock Jumps After CEO Anthony Pompiliano Accepts $1 Salary With Stock Incentives</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Quantum Computing, Quantum Physics, Quantum mechanics, Science, Technology. (Representative image courtesy of Just_Super via Getty Images)

Why Did QCLS Stock Surge Over 60% Today?

QCLS shares rallied after American pharma investor Martin Shkreli said on X that he had bought the stock, giving it a near-term price target of $100. 

<ul class="summary-bullets"><li>The stake sale comes on the heels of the company increasing its stake in TNF Pharmaceuticals in September by an additional $3 million.&nbsp;</li><li>PharmaCyte said that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.&nbsp;</li><li>The company said that monetizing its stake in Femasys will help strengthen its financial position.</li></ul> PharmaCyte Biotech, Inc. (PMCB) said on Tuesday that it sold its stake in Femasys Inc. (FEMY), thereby increasing its cash and marketable securities to about $20 million.The company had cash and marketable securities of only about $13.3 million as of the end of July. The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.pharmacyte.com/press-releases/detail/319/pharmacyte-biotech-successfully-monetizes-femasys-stake">said</a> that monetizing its stake in Femasys will help strengthen its financial position.Shares of <a href="https://stocktwits.com/symbol/PMCB">PMCB </a>traded 25% higher at the time of writing.<h2 class="st-heading-2">PharmaCyte’s Financial Position</h2>CEO Josh Silverman stated that the successful monetization of the Femasys position demonstrates the effectiveness of the strategic and disciplined capital allocation approach. “We are committed to deploying shareholder capital intelligently, balancing near-term returns with opportunities that can deliver sustained value creation,” he said.Overall, PharmaCyte now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash. The company highlighted its low stock price below $1 and added that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.The stake sale comes on the heels of the company increasing its stake in Q/C Technologies, formerly known as TNF Pharmaceuticals, in September by an additional $3 million.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around PMCB jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.A Stocktwits user opined that the news shows the company has ways to generate cash without doing share offerings.<stembedurl>https://stocktwits.com/MadBat/message/637404061</stembedurl>Another expects the stock to cross the $1 threshold.<stembedurl>https://stocktwits.com/cbt2020/message/637412358</stembedurl>PMCB stock fell 48% this year and by about 53% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nio-stock-slips-after-q4-revenue-guidance-disappoints/cL52NcEREgI">Nio Stock Slips After Q4 Revenue Guidance Disappoints</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

PMCB Stock Jumps 25% After Company Sells Stake In Femasys

PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.

Q/C Technologies, Inc. (QCLS) stock surged 15% in the premarket session and became the top trending ticker among equities on Stocktwits on Friday morning. The stock is on its way toward the $6 mark, last seen in August this year.The stock has garnered significant retail attention in recent days following the firm's announcement of a shift in focus to high-performance computing tailored for the cryptocurrency space. Momentum around quantum computing, triggered by recent&nbsp;advancements in both quantum hardware and software, along with efforts to build more powerful quantum machines, also helped build interest around the stock.Formerly known as&nbsp;TNF Pharmaceuticals Inc., the company changed its name to Q/C Technologies to reflect its focus towards quantum-class computing, catering to crypto and blockchain applications.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/QCLS">Q/C Technologies' stock</a>&nbsp;jumped to ‘extremely bullish’ from ‘neutral’ territory the previous day. Message volume improved to ‘extremely high’ from ‘low’ levels in 24 hours.&nbsp;On September 24, the company stated that it secured exclusive worldwide rights to a laser-based processor developed by LightSolver. This light-speed laser processing unit (LPU) boosts computing by leveraging the speed and efficiency of photons over traditional semiconductor methods.LightSolver’s LPU is said to reduce power usage by up to 90% while outperforming current graphics processing units (GPUs) and quantum computing platforms in both speed and reliability. In addition to performance improvements, the system provides enhanced security for blockchain networks, a feature of growing importance for decentralized finance and cryptocurrency protocols.Q/C Technologies’ stock has lost over 96% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/howard-lutnick-pushes-back-on-nvidia-uae-ai-chip-deal-report-says/chCu4zUR3fi">Howard Lutnick Pushes Back On Nvidia’s Multi-Billion-Dollar UAE AI Chip Deal? Report Says Delay Leaves Jensen Huang Frustrated</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A quantum computer being built by the start-up IQM Germany is located in a data center.

QCLS Stock Surges 15% In Pre-Market Today, Inches Closer To $6 Mark 

The stock has garnered significant retail attention in recent days following the firm's announcement of a shift in focus to high-performance computing tailored for the cryptocurrency space. 

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

QCLS
Q/C Technologies Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest QCLS News

QCLSQ/C Technologies Inc.